Yesterday, maternity-care-management platform Dorsata scored $5.2 million in Series A funding. Women’s Health USA, QED Investors, LabCorp, Fool Ventures and Gore Range Capital participated in this round.
WHAT THEY DO
Dorsata entered the market in late 2017, with its tool designed to help prevent variations in medical care during maternity and decrease the rate of preventable complications.
“We work with OBGYNs as their primary tool in the exam room for all of their documentation, care plans and order entry,” David Fairbrothers, cofounder and CEO of Dorsata, told MobiHealthNews in February.
“So, you can think about it like an EMR, except we are deeply integrated into the EMR. So, in fact we become that provider’s partner in seeing their patients. We look at all the clinical data that exists on that patient in their medical record – anything that they are documenting. Then we run that through a rules engine we built that is informed by the American College of Obstetricians and Gynecologists, and present it back to gynecologist as a precise plan of care that is appropriate for that patient based on all of that information.”
WHAT IT’S FOR
The company plans to use the new funds to integrate Dorsata into new EHR systems and bring the system to new providers and patients.
Women’s health has increasingly become more on the radar for digital companies leading to the emergence of maternity-focused startups. One such company is Mahmee, a Lost Angeles-based platform that offers pre- and postpartum support to mothers and providers. It works within a provider’s IT network to link the health records of the mother and baby.
ON THE RECORD
“Ob-Gyn providers are suffering on a number of fronts, whether through the burdens associated with clerical work or the complexities of new value-based care programs. We look forward to expanding our collaboration with the American College of Obstetricians and Gynecologists, as well as growing and supporting our customer base through these challenging times,” Fairbrothers said in a statement. “The fresh capital will in part support launching our first pilot customer on NextGen over the next 30 days, enable continued investment in our core product suite, and develop future EHR integrations.”